$1.7 B

INSM Mkt cap, 20-Sep-2018
Insmed Net income (Q2, 2018)-145 M
Insmed EBIT (Q2, 2018)-135.6 M
Insmed Cash, 30-Jun-2018634.3 M
Insmed EV1.3 B

Insmed Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

11.5 m

Revenue growth, %

(100%)

R&D expense

122.7 m

General and administrative expense

50.7 m

Operating expense total

173.4 m

EBIT

(55 m)(87.4 m)(117.5 m)(173.4 m)

EBIT margin, %

(478%)

Interest expense

2.4 m2.4 m2.9 m3.5 m

Pre tax profit

(57.3 m)(89.6 m)(120.2 m)(176.2 m)

Income tax expense

98 k

Net Income

(56.1 m)(79.2 m)(118.2 m)(176.3 m)

Quarterly

USDQ3, 2013Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

R&D expense

12.1 m14.9 m15.2 m17.2 m18.2 m19.2 m20.5 m23.9 m23.4 m22.3 m26.9 m26.7 m30.1 m65.8 m

General and administrative expense

4.7 m7.9 m8.2 m9.5 m9.7 m11 m12.5 m12.3 m13.7 m13.7 m16.6 m17.4 m32.7 m69.8 m

Operating expense total

16.8 m22.8 m23.4 m26.7 m28 m30.2 m33.1 m36.1 m37.1 m36 m43.5 m44.1 m62.8 m135.6 m

EBIT

(16.8 m)(22.8 m)(23.4 m)(26.7 m)(28 m)(30.2 m)(33.1 m)(36.1 m)(37.1 m)(36 m)(43.5 m)(44.1 m)(62.8 m)(135.6 m)

Interest expense

525 k595 k594 k722 k718 k725 k622 k624 k769 k1.5 m1.5 m1.5 m5.6 m12.1 m

Pre tax profit

(17.3 m)(23.2 m)(24 m)(27.4 m)(28.6 m)(31 m)(33.5 m)(36.6 m)(37.7 m)(37.4 m)(44.6 m)(45.2 m)(68.5 m)(144.9 m)

Income tax expense

28 k18 k25 k30 k37 k27 k48 k88 k

Net Income

(17.3 m)(37.5 m)(61.5 m)(27.4 m)(56 m)(86.9 m)(33.5 m)(36.6 m)(37.8 m)(37.4 m)(44.7 m)(45.2 m)(68.5 m)(145 m)

Insmed Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

113.9 m159.2 m282.9 m162.6 m

Accounts Receivable

39.3 m

Inventories

2.3 m5.5 m5.2 m5.8 m

Current Assets

116.2 m164.7 m288.1 m168.4 m

Total Assets

176.5 m230.9 m356.6 m238 m

Accounts Payable

5.9 m9.2 m7.5 m10.4 m

Short-term debt

3.1 m3.1 m

Current Liabilities

16.5 m19.6 m22.3 m28 m

Total Debt

3.1 m

Total Liabilities

83.5 m

Additional Paid-in Capital

534.6 m656.5 m900 m919.2 m

Retained Earnings

(391.6 m)(470.8 m)(589 m)(765.2 m)

Total Equity

143.3 m186.2 m311.7 m154.5 m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

1.2 x1.2 x1.1 x1.5 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

128 m101.3 m82.7 m167.3 m134.6 m335 m311 m252.9 m223.1 m200.5 m125.8 m91.1 m430.7 m686.6 m634.3 m

Current Assets

129.7 m106.2 m86.7 m170.8 m140.2 m342.1 m319.3 m258.5 m229.3 m206.3 m131.6 m96.5 m437.5 m696.4 m645.3 m

PP&E

15.8 m17.9 m

Total Assets

190 m166.6 m150.1 m235.4 m206.2 m408.5 m385.7 m327.7 m299.7 m276.6 m200.7 m165.6 m506.2 m773.2 m724.2 m

Accounts Payable

4.7 m9.8 m11.4 m8.9 m7.9 m8.7 m10.9 m8.7 m9.4 m8.3 m8.5 m11 m9.3 m13.2 m16 m

Short-term debt

25.1 m25.3 m5.7 m8.7 m3.1 m

Current Liabilities

19.8 m20 m21.8 m21.3 m41.1 m43.1 m46.7 m25.5 m32.3 m23.5 m23.3 m26.3 m28.8 m34.8 m45.6 m

Long-term debt

302.7 m307.2 m

Total Debt

25.1 m25.3 m5.7 m8.7 m3.1 m302.7 m307.2 m

Total Liabilities

32.8 m34.9 m38.6 m36.2 m41.3 m43.2 m46.7 m45.2 m49.1 m58.8 m79 m82.2 m84.9 m338.3 m353.6 m

Additional Paid-in Capital

532.1 m537.3 m540.3 m651.9 m662.5 m891.5 m896.1 m904.3 m909 m914 m923.8 m930.2 m1.3 b1.5 b1.5 b

Retained Earnings

(375.4 m)(405.9 m)(429.1 m)(453.1 m)(498.1 m)(526.8 m)(557.7 m)(622.5 m)(659.1 m)(696.8 m)(802.7 m)(847.3 m)(892.5 m)(1 b)(1.1 b)

Total Equity

157.1 m131.7 m111.5 m199.3 m164.9 m365.3 m339 m282.5 m250.6 m217.8 m121.7 m83.4 m421.3 m434.9 m370.6 m

Financial Leverage

1.2 x1.3 x1.3 x1.2 x1.3 x1.1 x1.1 x1.2 x1.2 x1.3 x1.6 x2 x1.2 x1.8 x2 x

Insmed Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(56.1 m)(79.2 m)(118.2 m)(176.3 m)

Depreciation and Amortization

680 k1.1 m2 m2.4 m

Accounts Receivable

757 k

Accounts Payable

(1.1 m)3.3 m(1.8 m)2.8 m

Cash From Operating Activities

(46.7 m)(64.4 m)(100.7 m)(146.7 m)

Purchases of PP&E

(826 k)(5.4 m)(3.5 m)(4.2 m)

Cash From Investing Activities

1.3 m(4.2 m)

Cash From Financing Activities

68.4 m115.1 m227.8 m30.7 m

Interest Paid

1.8 m1.8 m2.9 m3.6 m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(39.9 m)(14.3 m)(37.5 m)(61.5 m)(27.4 m)(56 m)(86.9 m)(33.5 m)(70.1 m)(107.9 m)(37.4 m)(82.1 m)(127.3 m)(68.5 m)(145 m)

Depreciation and Amortization

475 k167 k342 k697 k432 k879 k1.3 m514 k1.1 m1.8 m716 k1.5 m2.2 m769 k1.7 m

Accounts Payable

(2.4 m)3.9 m3.6 m2.5 m(1.4 m)(981 k)1.3 m527 k1.2 m361 k(2 m)767 k(921 k)(828 k)2 m

Cash From Operating Activities

(32.6 m)(12.6 m)(30.6 m)(51.5 m)(24.9 m)(49.1 m)(73.2 m)(29.5 m)(57.8 m)(88.7 m)(36.9 m)(73.2 m)(111.4 m)(68 m)(123 m)

Purchases of PP&E

(713 k)(331 k)(1.3 m)(2.2 m)(3 m)(588 k)(2.1 m)(3.4 m)(417 k)(854 k)(1.3 m)(5.4 m)(8.2 m)

Cash From Investing Activities

1.4 m(331 k)(895 k)(1.3 m)(2.2 m)(3 m)(588 k)(2.1 m)(3.4 m)(417 k)(854 k)(1.3 m)(5.4 m)(8.2 m)

Cash From Financing Activities

68.4 m337 k277 k108.7 m1.5 m227.1 m227.9 m81 k128 k9.8 m565 k2.4 m380.7 m378.8 m384.3 m

Interest Paid

1.4 m463 k930 k1.4 m663 k1.5 m2.2 m975 k1.6 m2.5 m1.3 m2.6 m3.9 m1.3 m1.3 m

Income Taxes Paid

17 k41 k62 k54 k93 k

Insmed Ratios

USDY, 2018

EV/EBIT

-9.9 x

EV/CFO

-11 x

Financial Leverage

2 x
Report incorrect company information